Drugs manufacturers seek deregulation for R&D sites
The pharmaceuticals sector is challenging an Environment Agency ruling that research and development facilities should be regulated under the pollution prevention and control (PPC) regime.
Sorry you do not have access to this article. Please contact Customer Support at
or call 020 8267 8120